Related Experiment Video
Updated: Feb 4, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Resistant Hypertension: A Real Entity Requiring Special Treatment?
Stefano Taddei1, Rosa Maria Bruno1,2
1University of Pisa, Pisa, Italy.
Resistant hypertension (RH) is defined as uncontrolled blood pressure despite three medications. This review examines the definition's utility and treatment implications.
Area of Science:
- Cardiology
- Nephrology
- Pharmacology
Background:
- Resistant hypertension (RH) is defined as blood pressure uncontrolled despite three antihypertensive agents at full doses, including a diuretic.
- The definition aims to identify patients needing further evaluation for optimal blood pressure control.
- Overly simplistic views may lead to classifying RH as a distinct entity requiring specialized, costly treatments.
Purpose of the Study:
- To critically evaluate the current definition of resistant hypertension.
- To discuss the clinical utility and limitations of the RH definition.
- To explore the implications of the RH definition on patient treatment strategies.
Main Methods:
- Literature review of studies on resistant hypertension definition and management.
- Analysis of the clinical implications of the current RH definition.
- Discussion of current and emerging treatment options for RH.
Main Results:
- The current definition of RH, while useful for identifying patients needing further assessment, may be oversimplified.
- This oversimplification can lead to the misclassification of RH as a separate disease entity.
- Potential consequences include the unnecessary use of expensive, specialized treatments.
Conclusions:
- The definition of resistant hypertension requires careful consideration of its utility and limitations.
- A nuanced approach to RH is necessary to ensure appropriate and cost-effective patient management.
- Further research is needed to refine the definition and guide treatment decisions.
Related Concept Videos
Treatment Resistant Cancers
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Requirements for Human Life
Oxygen
Atmospheric air is only about 20 percent oxygen, but that oxygen is a key component of the chemical reactions that keep the body alive, including the reactions that produce ATP. Brain cells are susceptible to a lack of oxygen because they require a...

